Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03932812 · ClinicalTrials.gov registry record · NA
Building a Bridge (BAB) Between Clinical and Community Care
A NA study of Caregiver Burden, sponsored by Sato Ashida.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT03932812: Completed NA study of Caregiver Burden, sponsored by Sato Ashida.
NCT03932812 is a NA study of Caregiver Burden that has completed, run by Sato Ashida. The registered enrollment target is 82 participants, below the 243-participant average among 41 other Caregiver Burden trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03932812, a NA study of Caregiver Burden, has completed, sponsored by Sato Ashida.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
Dementia diagnosis triggers a transitional phase for the individuals and their families, often causing emotional distress and family conflicts due to the ambiguity of the illness and future trajectories. Families often report a lack of information and guidance during the period immediately following diagnosis, suggesting a missed opportunity for prevention of family distress at the outset of the caregiver and patient career. With large and increasing numbers of individuals newly diagnosed with Alzheimer's Disease and Related Dementias (ADRD) each year, there is an urgent need to develop effective intervention models to support role transitions and minimize distress related to ADRD diagnosis. The long-term goal of this research is to minimize negative consequences of ADRD by enhancing the support systems of the affected families as they start their new and challenging phase of life as patients and family caregivers. The aim of this research is to evaluate the impact of this new Options Counselor-Health Education (OC-HE) intervention on bridging the medical and community-settings through potential mechanisms of influence, enhancement of social networks and support. Implementation strategies will be developed in collaboration with partnering clinics and local Area Agencies on Aging. Participants will be recruited from three clinics at the University of Iowa Hospitals and Clinics (UIHC) that provide dementia diagnostic services and randomized into an intervention or control arm; and complete baseline and three- and six-month follow-up interviews. This study is innovative in its consideration of contributing factors at multiple levels of the ecological model (i.e., individual, social network, and organizational) and its collaborative approach, involving medical clinics, an Area Agency on Aging (AAA), and Alzheimer's Association (AA) to develop and evaluate a new care model that bridges between the medical and community settings.
Primary Outcome
Caregiver burden 12 item self report questionnaire; Minimum score 0, maximum score 36 with low scores showing less burden
Conditions Studied
Interventions
- BEHAVIORAL Options Counselor Health Educator (OC-HE) Intervention
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2021-10-31 |
| Phase | NA |
What the finished NCT03932812 record still lists
NCT03932812 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 243-participant average among 41 other Caregiver Burden trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Caregiver Burden appearing as the primary indexed condition, and to 1 intervention - of which Options Counselor Health Educator (OC-HE) Intervention is the first listed.
NCT03932812 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT03932812 about?
NCT03932812 is a clinical study titled "Building a Bridge (BAB) Between Clinical and Community Care". Dementia diagnosis triggers a transitional phase for the individuals and their families, often causing emotional distress and family conflicts due to the ambiguity of the illness and future trajectories. Families often report a lack of information and guidance during the period immediately following...
What is the current status of trial NCT03932812?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2019-08-01. Estimated completion is 2021-10-31.
What conditions does trial NCT03932812 study?
This clinical trial studies the following conditions: Caregiver Burden.
What interventions are being tested in trial NCT03932812?
The interventions under investigation include: Options Counselor Health Educator (OC-HE) Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03932812?
This trial is sponsored by Sato Ashida, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03932812 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caregiver Burden
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03932812's enrollment target sits among peer trials
82 22nd of 41 higher than 20 of 41 other Caregiver Burden trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Caregiver Burden trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Telephone Support in Advanced Gastrointestinal Cancer
RECRUITING · NA
-
Support Via Technology: Living and Learning With Advancing Dementia-REVISED
RECRUITING · NA
-
DECIDE: Dyads and Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI